Resultats de la cerca - Massimo Di Maïo

Refinar resultats
  1. 1
    Quality of Life in elderly patients with cancer.

    Quality of Life in elderly patients with cancer. per Massimo Di Maïo, Federica Perrone

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles

    Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles per Antônio Rossi, Massimo Di Maïo

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    A review of guidelines for lung cancer

    A review of guidelines for lung cancer per Paolo Bironzo, Massimo Di Maïo

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review

    Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review per Anna Amela Valsecchi, Massimo Di Maïo

    Publicat 2025
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations per Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

    Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials per Francesco Facchinetti, Massimo Di Maïo, Marcello Tiseo

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy

    A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy per Massimo Di Maïo, Federica Perrone, Claude Deschamps, Gaetano Rocco

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice

    COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice per Laura Marandino, Andrea Necchi, Massimo Aglietta, Massimo Di Maïo

    Publicat 2020
    Obtenir text complet
    Editorial
    Afegir a favorits
    Guardat en:
  9. 9
    Papillary renal cell carcinoma: A review of the current therapeutic landscape

    Papillary renal cell carcinoma: A review of the current therapeutic landscape per Giulia Courthod, Marcello Tucci, Massimo Di Maïo, Giorgio V. Scagliotti

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

    Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-... per Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maïo

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

    Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions per Alessandro Morabito, Ermelinda De Maio, Massimo Di Maïo, Nicola Normanno, Federica Perrone

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer

    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer per Consuelo Buttigliero, Marcello Tucci, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer

    Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer per Francesca Vignani, Valentina Bertaglia, Consuelo Buttigliero, Marcello Tucci, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

    Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions per Marcello Tucci, Clizia Zichi, Consuelo Buttigliero, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

    Tackling ALK in non-small cell lung cancer: the role of novel inhibitors per Francesco Facchinetti, Marcello Tiseo, Massimo Di Maïo, Paolo Graziano, Emilio Bria, Giulio Rossi, Silvia Novello

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer

    Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer per Consuelo Buttigliero, Marcello Tucci, Valentina Bertaglia, Francesca Vignani, Paolo Bironzo, Massimo Di Maïo, Giorgio V. Scagliotti

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Neuroendocrine breast carcinoma: a rare but challenging entity

    Neuroendocrine breast carcinoma: a rare but challenging entity per Elena Trevisi, Anna La Salvia, Lorenzo Daniele, Maria Pia Brizzi, Gaetano De Rosa, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  18. 18
    Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆

    Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆ per Mario De Bellis, Rosanna Accardo, Massimo Di Maïo, Carmine Lamanna, Giovanni Battista Rossi, Maria Caterina Pace, Vincenzo Romano, Gaetano Rocco

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer per Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    Publicat 2007
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Implications of KRAS mutations in acquired resistance to treatment in NSCLC

    Implications of KRAS mutations in acquired resistance to treatment in NSCLC per Marzia Del Re, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, E. Arrigoni, Stefano Fogli, Massimo Di Maïo, Iacopo Petrini, Romano Danesi

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: